Keywords: vicuron, anti-fungal, superior, pfizer, results, phase, iii

Vicuron's anti-fungal "superior" to Pfizer's

Article | 14 February 2005

Print This

Results of a Phase III clinical trial have demonstrated that Vicuron Pharmaceuticals' anidulafungin appears superior in efficacy to fellow US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in